Translate Bio Signs Lease for Site in Waltham

Posted by ISPE Boston
On November 12, 2020

Boston Properties has announced a 138,000 square-foot, 10-year lease with Lexington-based Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, at 200 West Street in Waltham. Boston Properties is currently redeveloping 200 West Street into lab space with expected completion in 2021. Translate Bio is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases […]

Lilly’s mAb Receives FDA Emergency Use Authorization for COVID Treatment

Posted by ISPE Boston
On November 12, 2020

The FDA has granted Emergency Use Authorization (EUA) for Eli Lilly’s investigational drug bamlanivimab, a recombinant, neutralizing human IgG1 monoclonal antibody (mAb) directed against the spike protein of SARS-CoV-2. Bamlanivimab is designed to block viral attachment and entry into human cells, thus neutralizing the virus, potentially treating COVID-19. Bamlanivimab emerged from the collaboration between Lilly and AbCellera to create […]

Chapter Member Anniversaries: November 2020

Posted by ISPE Boston
On November 5, 2020

Please congratulate the following members celebrating milestone anniversaries in November 2020. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Charles H. Brown, II, MS, Retired Timothy F. Curran, PE, NV5 Ronald J. Friedman, Exyte Donald A. Ross, BSCE, MSCE, A/Z Corp Pasquale M. Sacco, Translate Bio […]

Welcome New Members October 2020!

Posted by ISPE Boston
On November 5, 2020

We would like to introduce the Members who joined ISPE in October 2020, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And […]

Congratulations to Sanofi

Posted by ISPE Boston
On November 5, 2020

Congratulations to Sanofi, who was just named the 2020 Facility of the Year Awards (FOYA) Overall Winner at the 2020 FOYA Banquet during the virtual 2020 ISPE Annual Meeting & Expo. Sanofi was awarded the 2020 FOYA Facility of the Future Category Award in April 2020 for its Sanofi Digitally Enabled Integrated Continuous Biomanufacturing Facility in Framingham. This […]

PerkinElmer to Acquire Cell Engineering Company

Posted by ISPE Boston
On November 5, 2020

Waltham-based PerkinElmer will acquire cell engineering company Horizon for approximately $383 million with the transaction expected to close in the first quarter of 2021. With this investment, PerkinElmer will expand its portfolio of leading, automated life sciences discovery and applied genomics solutions to include gene editing and gene modulation tools. The acquisition will enable PerkinElmer […]

Foghorn Therapeutics IPO Raises $120 Million

Posted by ISPE Boston
On November 5, 2020

Cambridge biotech Foghorn Therapeutics’ common stock began trading on The Nasdaq Global Market on October 23. The gross proceeds of the initial public offering are expected to be approximately $120 million. Foghorn Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system which regulates which genes are expressed to […]

Scorpion Therapeutics Launches With $108 Million

Posted by ISPE Boston
On November 5, 2020

Scorpion Therapeutics has closed a $108 million Series A financing. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver the next generation of precision oncology medicines. Scorpion will focus initially on three key efforts: designing best or first-in-class drugs against known oncogenes; drugging known – but classically undruggable […]

Lilly to Acquire Disarm Therapeutics for $135 Million

Posted by ISPE Boston
On October 27, 2020

Eli Lilly has announced it will acquire Cambridge-based Disarm Therapeutics, a privately-held biotech creating a new class of disease-modifying therapeutics for patients with axonal degeneration, a central driver of neurological disability and disease progression. Disarm has discovered novel, potent SARM1 inhibitors and is advancing them in preclinical development, with the goal of delivering breakthrough treatments […]

Better Late Than Never (and a Hole-in-One)!

Posted by Dan Kenny
On October 26, 2020

Finally, 2020 allowed us out of the house and provided a beautiful day for the ISPE Boston Area Chapter to host a golf outing on October 19 at Blue Hills CC in Canton. The weather was perfect for golf and the excitement from the players was high! Unfortunately, because of the current climate, we had […]

Page 57 of 118«‹55 565758 59 ›»